If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaspian Sunrise Regulatory News (CASP)

  • This share is currently suspended. It was suspended at a price of 1.90

Share Price Information for Caspian Sunrise (CASP)

Share Price is delayed by 15 minutes
Get Live Data
1.90    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £44.77m
CASP Live PriceLast checked at - London Stock Exchange

Intraday Caspian Sunrise Share Chart

US$5 million additional funding from Arawak

18 Jun 2009 14:30

RNS Number : 1359U
Roxi Petroleum Plc
18 June 2009
 



Roxi Petroleum plc 

("Roxi or the "Company")

US$5 million additional funding from Arawak

US$5 million convertible loan from Arawak a subsidiary of the Vitol group 

US$3 million is earmarked to bring Galaz into production

US$2 million will be available for the for general administrative purposes

When taken in conjunction with the recently announced US$24 million GEM facility Roxi has in the past month put in place facilities to provide up to an additional US$29 million of funding

Roxi Petroleum plc ("Roxi" or "the Company"), the Kazakhstan based oil exploration and development company is pleased to announce additional funding from a leading industry participant. 

US$5 million Convertible loan

Roxi is pleased to announce that the Company has entered into an agreement with Arawak Energy Limited ("Arawak"), a subsidiary of the Vitol group, which is one of the world's largest oil traders, to provide a US$5 million loan to Roxi, principally to assist the Company to bring Roxi's Galaz assets into full production.

The loan will carry interest at 7 per cent above LIBOR and is repayable in 12 months at the Company's option. In the event it is not then repaid the loan will, based on today's exchange rate, convert into approximately 31 million Roxi shares at 10p per share.

Approximately US$3 million will be used to develop the Galaz assets to bring them into full production. Approximately US$2 million will be available for general administrative purposes.

In consideration for entering into the loan agreement Roxi will issue Arawak warrants to subscribe for up to 18 million Roxi shares, exercisable before 31  March 2010 at a price of 10p per share, or before 30 September 2010 at 15p per share, or before 31 March 2011 at 20p per share. 

The board believes that the proposed US$5 million convertible loantaken together with funding available under the recently announced US$24 million GEM facility, will provide a far greater level of financial stability that has existed of late and allow the management to focus on the development of the Company's assets. 

Related party transaction

A condition of the loan is that it ranks ahead of loans made by Mr Kuat Oraziman, a director of Roxi. Accordingly, Mr Kuat Oraziman, , has agreed to defer repayment on US$14.5 million existing loans due for repayment in June and July 2009. In return for agreeing to subordinate these loans to Arawak and to extend the repayment dates Roxi has agreed to place US$10 million of his loans on the same commercial terms as negotiated with Arawak. 

Therefore US$10 million of Mr Oraziman's loans will from the date of drawdown under the Arawak loan earn interest at the rate of 7 per cent above LIBOR. Additionally Mr Oraziman will be issued with 36 million warrants exercisable on the same terms as Arawak.

The changes to Mr Oraziman's loans to Roxi constitute related party transactions under the AIM Rules for companies. Roxi's directors, other than Mr Oraziman, after consulting with WH Irelandthe Company's nominated adviser, consider the revised terms of his loans together with the granting of the 36 million warrants fair and reasonable in so far as shareholders are concerned. 

Rob Schoonbrood CEO commented

 "I am delighted that we have been able to secure this substantial new funding - from  top quality partner, with experience in Kazakhstan and who are well aware of the potential of emerging markets oil and gas.

The Arawak funding will, greatly aid our efforts to bring our Galaz asset into production, 

Following a tough year in capital markets, we believe that with this combination of new funding, and a positive outlook operationally, there is every reason for cautious confidence for the future." 

18 June 2009

Enquiries: 

Roxi Petroleum plc

Rob Schoonbrood, CEO +7 727 244 0920

College Hill (Financial PR)

Paddy Blewer / Nick Elwes +44 (0) 20 7457 2020

WH Ireland (NOMAD and broker)

James Joyce +44 (0)20 7220 1666

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUWAORKNRNAAR
Date   Source Headline
26th Sep 202412:59 pmRNSGeneral Meeting Results
25th Sep 20247:00 amRNSInterim results for six months ended 30 June 2024
4th Sep 20247:00 amRNSDisposal of the shallow MJF & Notice of GM
3rd Sep 20247:00 amRNSProposed disposal of MJF & South Yelemes
2nd Sep 20242:27 pmRNSGeneral Update
18th Jul 20247:00 amRNSUpdate on Proposed Sale
15th Jul 20248:50 amRNSRestoration - Caspian Sunrise plc
15th Jul 20247:39 amRNSPosting of Accounts
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
15th Jul 20247:00 amRNSAnnual Report for the Year Ended 31 December 2023
12th Jul 202412:38 pmRNSGeneral Update
8th Jul 20241:43 pmRNSUpdate
2nd Jul 20247:00 amRNSOperational Update
1st Jul 20247:30 amRNSSuspension - Caspian Sunrise plc
27th Jun 20243:42 pmRNSResult of AGM
27th Jun 20247:01 amRNSGeneral Update / AGM statement
27th Jun 20247:00 amRNSPreliminary Unaudited Results year end 31 Dec 2023
14th Jun 202410:42 amRNSReserve update
3rd Jun 20249:21 amRNS2024 AGM
14th May 20247:00 amRNSProposed Sale of the BNG shallow structures
25th Apr 20241:08 pmRNSGeneral Meeting Results
24th Apr 20247:00 amRNSIssue of Equity and Option Awards
8th Apr 20247:00 amRNSProposed Acquisition, Rule 9 Waiver and GM Notice
25th Mar 20247:00 amRNSStrategic & Operational Update
16th Feb 20247:00 amRNSBNG Operational update
21st Dec 20237:00 amRNSOperational Update
31st Oct 20237:00 amRNSOperational update
25th Sep 20237:00 amRNSInterim results for six months ended 30 June 2023
31st Jul 202312:49 pmRNSGM results
31st Jul 20237:00 amRNSGeneral Meeting & BNG and Caspian Explorer updates
11th Jul 202312:50 pmRNSHolding(s) in Company
10th Jul 20237:00 amRNSBoard change, Posting of the 2022 Results
7th Jul 20237:30 amRNSRestoration- Caspian Sunrise plc
7th Jul 20237:00 amRNSAnnual Report for the Year Ended 31 December 2022
3rd Jul 20237:30 amRNSSuspension - Caspian Sunrise plc
30th Jun 20233:51 pmRNSAGM results
30th Jun 20237:00 amRNSAGM Statement
12th Jun 20237:00 amRNS50% Sale of Caspian Explorer & Operational Update
1st Jun 20239:26 amRNSAGM and 2022 Accounts update
7th Mar 20237:00 amRNSCaspian Explorer contract signed & Dividend update
20th Feb 20237:00 amRNSCaspian Explorer update & Dividend update
30th Jan 20237:00 amRNSDeep well update
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
16th Jan 20232:05 pmRNSSecond Price Monitoring Extn
16th Jan 20232:00 pmRNSPrice Monitoring Extension
16th Jan 202311:05 amRNSSecond Price Monitoring Extn
16th Jan 202311:00 amRNSPrice Monitoring Extension
16th Jan 20237:00 amRNSTender Update
12th Jan 20237:00 amRNSThird Monthly Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.